Mira PharmaceuticalsMIRA
13F holders, Q1 2024 (March 31)11holders
$1.10avg. 13F price*
At the end of Q1 2024, 11 institutions reported holding Mira Pharmaceuticals Inc. (MIRA) in their 13F filings. The largest holders were Cross Staff Investments Inc ($422K), Virtu Financial LLC ($69K) and Suncoast Equity Management ($44K).
- Company
- Mira Pharmaceuticals Inc.
- CUSIP
- 60458C104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $612K |
| Exits | 4 | $66K |
Ownership 11 holders
| Cross Staff Investments Inc | 0.36% | New | 383,401 | $422K |
| Virtu Financial LLC | 0.01% | Add +330.2% | 63,055 | $69K |
| Suncoast Equity Management | 0.01% | New | 40,000 | $44K |
| HRT Financial LP | 0.00% | New | 30,651 | $33K |
| Praetorian Wealth Management, Inc. | 0.01% | New | 27,500 | $30K |
| XTX Topco Ltd | 0.00% | New | 25,544 | $28K |
| Northern Trust Corp. | 0.00% | No change | 20,454 | $23K |
| First American Bank | 0.00% | New | 20,000 | $22K |
| Susquehanna International Group, LLP | 0.00% | New | 15,573 | $17K |
| Cary Street Partners Investment Advisory LLC | 0.00% | New | 10,000 | $11K |
| UBS Group AG | 0.00% | New | 4,771 | $5K |
"% of holder's portfolio" is MIRA's weight in each manager's 13F, not the share of Mira Pharmaceuticals Inc. the manager owns.